Aptevo Therapeutics APVO
NASDAQ APVO
$1.76 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Aptevo Therapeutics (APVO) Return on Assets [ROA] (2016 - 2026)

Updated

Aptevo Therapeutics (APVO) reported Return on Assets [ROA] of -154.90% for Q2 2026, up 45.59 percentage points from -200.49% a year earlier but down 42.33 percentage points from the prior quarter.

Analysis

Aptevo Therapeutics (APVO) Return on Assets [ROA] (2016 - 2026) Analysis & Trends

For FY2025, Aptevo Therapeutics posted Return on Assets [ROA] of -121.38%, down 2.03 percentage points from FY2024.

  • Return on Assets [ROA] has declined for three consecutive years, with a five-year change of -88.19 percentage points (FY2020 to FY2025).
  • By year, Return on Assets [ROA] came in at -119.36% in FY2024 (-60.39 pp), -58.96% in FY2023 (-76.64 pp), 17.68% in FY2022 (+69.35 pp) and -51.67% in FY2021 (-18.48 pp).
  • Five-year quarterly Return on Assets [ROA] spans a low of -200.49% in Q2 2025 and a high of 53.47% in Q1 2023.
  • Year over year, Return on Assets [ROA] has now increased in each of the last four quarters, with an average year-over-year change of -10.44 percentage points over the last eight quarters.
  • The high point for year-over-year Return on Assets [ROA] in five years was Q1 2023 (a gain of 110.25 percentage points); the low point was Q1 2024 (a drop of 180.71 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -112.57% (Q1 2026), -96.76% (Q4 2025) and -124.51% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 20.64%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 10.47%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 4.65%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.45%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 28.37%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.10%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 9.29%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -6.13%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 2.14%
10 Aptevo Therapeutics 2.50 Mn -64.50 Mn - -154.90%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -154.90%
Mar 31, 2026 -112.57%
Dec 31, 2025 -96.76%
Sep 30, 2025 -124.51%
Jun 30, 2025 -200.49%
Mar 31, 2025 -198.09%
Dec 31, 2024 -157.01%
Sep 30, 2024 -157.79%
Jun 30, 2024 -153.33%
Mar 31, 2024 -127.24%
Dec 31, 2023 -67.01%
Sep 30, 2023 -57.64%
Jun 30, 2023 -54.67%
Mar 31, 2023 53.47%
Dec 31, 2022 24.36%
Sep 30, 2022 18.15%
Jun 30, 2022 16.77%
Mar 31, 2022 -56.78%
Dec 31, 2021 -47.19%
Sep 30, 2021 -43.16%
API Access

Aptevo Therapeutics Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=APVO&period=max&api_key=YOUR_API_KEY